Financials
Financial year 2025
BeSt Pharma Management from Ranst, company number BE0794803647, closed financial year 2025 with a result of € 209,412 after tax. For that financial year BeSt Pharma Management recorded a gross margin of € 320,360 and equity of € 365,974. Compared with financial year 2024, the result moved from € 70,240 to € 209,412. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 365,974
▲ 134% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 209,412
▲ 198% vs 2024
Profit after tax over the fiscal year.
€ 29,734
▼ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 359,974.
Debts at end 2025
€ 908,333
▼ 8% vs 2024
€ 85,470 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 3,923
▼ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 94,073
▲ 82% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 141,125 | € 129,177 | € 320,360 | ▲ 148% |
| Profit after taxes | € 80,322 | € 70,240 | € 209,412 | ▲ 198% |
| Equity | € 86,322 | € 156,562 | € 365,974 | ▲ 134% |
| Total debts | € 1,224,536 | € 1,163,626 | € 1,125,962 | ▼ 3% |
| Cash | € 49,638 | € 51,142 | € 29,734 | ▼ 42% |
| Retained profit | € 80,322 | € 150,562 | € 359,974 | ▲ 139% |
| Bank debt | € 1,069,913 | € 990,644 | € 908,333 | ▼ 8% |
| Balance sheet total | € 1,310,858 | € 1,320,188 | € 1,491,936 | ▲ 13% |
Key figures of BeSt Pharma Management, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BeSt Pharma Management?
What happened at BeSt Pharma Management in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 209,412 (▲ 198% vs 2024). filed late Source: NBB ↗
- New establishment in Ranst. KBO
- Ben Geerinckx became a director. NBB
- Stéphanie De Ceuster became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 80,322 profit in 2023 to € 209,412 profit in 2025.
Paid € 103,570 in corporate taxes since 2023.
Best year ever: 2025, with € 209,412 profit.
A new publication or filing at BeSt Pharma Management? We notify you, reason included.
Follow BeSt Pharma ManagementDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BeSt Pharma Management are Ben Geerinckx and Stéphanie De Ceuster. It owns 100% of Oelegem Pharma itself.
Directors
According to the 2025 annual accounts
Ben Geerinckx
Director
since 2022
Stéphanie De Ceuster
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Knodbaan 76
2520 Ranst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0794.803.647
- VAT number
- BE 0794.803.647
- Registered office
- Knodbaan 76, 2520 Ranst
- Names & denominations
- BeSt Pharma Management
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 December 2022
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Activiteiten van holdings
Holdings